Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway

Journal of Cellular Biochemistry

Volumn 114, Issue 9, 2013, Pages 2101-2113

  Li, Guiying ^a,b   Li, Ying ^a   Liu, Shuxia ^a   Shi, Yonghong ^a   Chi, Yanqing ^a   Liu, Guijing ^b   Shan, Tieying ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI UNIVERSITY OF ENGINEERING   (China)

Author keywords

Gremlin1; Injury, Mouse Podocyte; SMAD; Transforming Growth Factor Beta1

Indexed keywords

GLUCOSE; GREMLIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; NEPHRIN; PROTEIN; SMAD PROTEIN; SMALL INTERFERING RNA; SYNAPTOPODIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DENSITOMETRY; DIABETIC NEPHROPATHY; GENE EXPRESSION; GENE SILENCING; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MOUSE; NICK END LABELING; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MUS;

EID: 84881387298     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24559     Document Type: Article

References (36)

1. Babayeva S, Zilber Y, Torban E,. 2011. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes. Am J Physiol Renal Physiol 300: F549-F560.
2. Benazet JD, Bischofberger M, Tiecke E, Goncalves A, Martin JF, Zuniga A, Naef F, Zeller R,. 2009. A self-regulatory system of interlinked signaling feedback loops controls mouse limb patterning. Science 323: 1050-1053.
3. Diez-Sampedro A, Lenz O, Fornoni A,. 2011. Podocytopathy in diabetes: A metabolic and endocrine disorder. Am J Kidney Dis 58: 637-646.
4. Dolan V, Murphy M, Alarcon P, Brady HR, Hensey C,. 2003. Gremlin-A putative pathogenic player in progressive renal disease. Expert Opin Ther Targets 7: 523-526.
5. Dolan V, Murphy M, Sadlier D, Lappin D, Doran P, Godson C, Martin F, O'Meara Y, Schmid H, Henger A, Kretzler M, Droguett A, Mezzano S, Brady HR,. 2005. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis 45: 1034-1039.
6. Dressler GR,. 2009. Advances in early kidney specification, development and patterning. Development 136: 3863-3874.
7. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P,. 2008. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938.
8. Ichimura K, Kurihara H, Sakai T,. 2003. Actin filament organization of foot processes in rat podocytes. J Histochem Cytochem 51: 1589-1600.
9. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S,. 2002. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62: 901-913.
10. Jefferson JA, Alpers CE, Shankland SJ,. 2011. Podocyte biology for the bedside. Am J Kidney Dis 58: 835-845.
11. Kistler AD, Altintas MM, Reiser J,. 2012. Podocyte GTPases regulate kidney filter dynamics. Kidney Int 81: 1053-1055.
12. Lappin DW, Hensey C, McMahon R, Godson C, Brady HR,. 2000. Gremlins, glomeruli and diabetic nephropathy. Curr Opin Nephrol Hypertens 9: 469-472.
13. Lappin DW, McMahon R, Murphy M, Brady HR,. 2002. Gremlin: An example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol Dial Transplant 17 (Suppl 9): 65-67.
14. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA,. 2006. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24: 99-146.
15. Li W, Cui M, Wei Y, Kong X, Tang L, Xu D,. 2012. Inhibition of the expression of TGF-beta1 and CTGF in human mesangial cells by exendin-4, a glucagon-like peptide-1 receptor agonist. Cell Physiol Biochem 30: 749-757.
16. McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie HS, Godson C, Martin F, Brady HR,. 2000. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem 275: 9901-9904.
17. Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A,. 2004. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131: 3401-3410.
18. Mitu GM, Wang S, Hirschberg R,. 2007. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol 293: F1641-F1648.
19. Moeller MJ, Holzman LB,. 2006. Imaging podocyte dynamics. Nephron Exp Nephrol 103: e69-e74.
20. Murphy M, McMahon R, Lappin DW, Brady HR,. 2002. Gremlins: Is this what renal fibrogenesis has come to ? Exp Nephrol 10: 241-244.
21. Murphy M, Crean J, Brazil DP, Sadlier D, Martin F, Godson C,. 2008. Regulation and consequences of differential gene expression in diabetic kidney disease. Biochem Soc Trans 36: 941-945.
22. Pache G, Schafer C, Wiesemann S, Springer E, Liebau M, Reinhardt HC, August C, Pavenstadt H, Bek MJ,. 2006. Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes. Am J Physiol Renal Physiol 291: F654-F662.
23. Pannu J, Nakerakanti S, Smith E, Dijke PT, Trojanowska M,. 2007. Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of smad1 and ERK1/2 pathways. J Biol Chem 282: 10405-10413.
24. Roxburgh SA, Murphy M, Pollock CA, Brazil DP,. 2006. Recapitulation of embryological programmes in renal fibrosis-The importance of epithelial cell plasticity and developmental genes. Nephron Physiol 103: 39-148.
25. Roxburgh SA, Kattla JJ, Curran SP, O'Meara YM, Pollock CA, Goldschmeding R, Godson C, Martin F, Brazil DP,. 2009. Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 58: 1641-1650.
26. Sethi A, Jain A, Zode GS, Wordinger RJ, Clark AF,. 2011. Role of TGFbeta/Smad signaling in gremlin induction of human trabecular meshwork extracellular matrix proteins. Invest Ophthalmol Vis Sci 52: 5251-5259.
27. Smerdel-Ramoya A, Zanotti S, Canalis E,. 2011. Nephroblastoma overexpressed (Nov) induces gremlin in ST-2 stromal cell lines by post-transcriptional mechanisms. J Cell Biochem 112: 715-722.
28. Wada J, Makino H, Kanwar YS,. 2002. Gene expression and identification of gene therapy targets in diabetic nephropathy. Kidney Int 61: S73-S78.
29. Wada J, Sun L, Kanwar YS,. 2011. Discovery of genes related to diabetic nephropathy in various animal models by current techniques. Contrib Nephrol 169: 161-174.
30. Wang SN, Lapage J, Hirschberg R,. 2001. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12: 2392-2399.
31. Wang S, de Caestecker M, Kopp J, Mitu G, Lapage J, Hirschberg R,. 2006. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17: 2504-2512.
32. Weil EJ, Lemley KV, Yee B, Lovato T, Richardson M, Myers BD, Nelson RG,. 2011. Podocyte detachment in type 2 diabetic nephropathy. Am J Nephrol 33 (Suppl 1): 21-24.
33. Wordinger RJ, Zode G, Clark AF,. 2008. Focus on molecules: Gremlin. Exp Eye Res 87: 78.
34. Zhang Y, Zhang Q,. 2009. Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy. Biochem Biophys Res Commun 383: 1-13.
35. Zhang Q, Shi Y, Wada J, Malakauskas SM, Liu M, Ren Y, Du C, Duan H, Li Y, Zhang Y,. 2010. In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7. PLoS ONE 5: e 11709.
36. Zhu B, Wang YJ, Zhu CF, Lin Y, Zhu XL, Wei S, Lu Y, Cheng XX,. 2010. Triptolide inhibits extracellular matrix protein synthesis by suppressing the smad2 but not the MAKP pathway in TGF-β1-stimulated NRK-49F cells. Nephrol Dial Transplant 25: 3180-3191.